We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
RNAi Screening of Rat Druggable Genes Using Sirna Design
Product News

RNAi Screening of Rat Druggable Genes Using Sirna Design

RNAi Screening of Rat Druggable Genes Using Sirna Design
Product News

RNAi Screening of Rat Druggable Genes Using Sirna Design


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "RNAi Screening of Rat Druggable Genes Using Sirna Design"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

QIAGEN has launched the Rat Druggable Genome siRNA Set V1.0. This set can enable potent and specific knockdown of approximately 6000 rat genes which correspond to human genes of therapeutic value.

The company has designed these siRNAs using HP OnGuard siRNA Design which incorporates a neural-network, proprietary homology analysis, and advanced design features based on the knowledge about the mechanism of RNAi. Subsets targeting 426 GPCR genes, 738 kinase genes, or 198 phosphatase genes are also available.

HP OnGuard siRNA Design includes an artificial neural-network for selection of highly potent siRNAs and stringent homology analysis to ensure specificity.

Additional features include design of siRNAs to target the sequences from NCBI, 3' UTR/seed region analysis, SNP avoidance, and interferon motif avoidance.

siRNA design is reinforced using the results from QIAGEN’s validation project in which thousands of siRNAs have been tested for effectiveness by real-time RT-PCR. Data from Affymetrix GeneChip analysis is used to minimize the potential for off-target effects.

The Rat Druggable Genome siRNA Set V1.0 is provided in flexible scales and formats to suit specific screening requirements. siRNAs are provided as individual siRNAs or pools for maximum flexibility.

Advertisement